Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
351
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $27.7M | 0.03% |
+1,413,166
| New | +$26.9M |
|
352
Glaukos
GKOS
$9.83B
| $27.6M | 0.03% |
425,889
-252,207
| -37% | -$12.4M |
|
|
SIVB
353
DELISTED
SVB Financial Group
SIVB
| $27.6M | 0.03% |
+88,753
| New | +$28M |
|
354
CME Group
CME
$96.3B
| $27.5M | 0.03% |
161,782
+155,328
| +2,407% | +$26.1M |
|
355
Valero Energy
VLO
$92.9B
| $27.4M | 0.03% |
240,533
+39,203
| +19% | +$4.45M |
|
356
Wendy's
WEN
$1.4B
| $27.1M | 0.02% |
1,579,385
-149,413
| -9% | -$2.61M |
|
|
DNKN
357
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $26.9M | 0.02% |
+365,184
| New | +$26.4M |
|
358
Lamb Weston
LW
$7.22B
| $26.3M | 0.02% |
+394,984
| New | +$27.1M |
|
359
Laureate Education
LAUR
$5.28B
| $26.2M | 0.02% |
1,697,214
-149,595
| -8% | -$2.3M |
|
360
Allison Transmission
ALSN
$9.5B
| $25M | 0.02% |
481,625
-606,481
| -56% | -$28.4M |
|
361
Olin
OLN
$2.11B
| $24.7M | 0.02% |
962,982
-15,983
| -2% | -$469K |
|
362
Ameris Bancorp
ABCB
$5.85B
| $24.7M | 0.02% |
540,229
-20,571
| -4% | -$1.02M |
|
363
DigitalBridge
DBRG
$2.93B
| $24.5M | 0.02% |
1,007,695
-8,615
| -0.8% | -$211K |
|
|
AQUA
364
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $24.5M | 0.02% |
1,379,133
-780,477
| -36% | -$15.3M |
|
365
Coca-Cola
KO
$377B
| $24.3M | 0.02% |
525,829
+170,203
| +48% | +$7.78M |
|
366
Verizon
VZ
$195B
| $24.3M | 0.02% |
+454,815
| New | +$24.1M |
|
367
Target
TGT
$65.6B
| $24.3M | 0.02% |
+275,249
| New | +$22.9M |
|
368
Q2 Holdings
QTWO
$3.8B
| $24.1M | 0.02% |
397,945
-356
| -0.1% | -$22K |
|
369
CRISPR Therapeutics
CRSP
$4.73B
| $24M | 0.02% |
+540,887
| New | +$28.3M |
|
370
MGP Ingredients
MGPI
$379M
| $24M | 0.02% |
303,406
+60,650
| +25% | +$4.93M |
|
|
P
371
Everpure Inc
P
$25.7B
| $23.9M | 0.02% |
920,251
-80,743
| -8% | -$2.01M |
|
372
ManpowerGroup
MAN
$2.44B
| $23.7M | 0.02% |
+275,311
| New | +$24.5M |
|
|
QVCGA
373
DELISTED
QVC Group Inc Series A
QVCGA
| $23.6M | 0.02% |
21,879
-1,894
| -8% | -$1.99M |
|
|
EPZM
374
DELISTED
Epizyme, Inc
EPZM
| $23.3M | 0.02% |
2,201,037
+16,249
| +0.7% | +$185K |
|
|
TVTY
375
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $23.1M | 0.02% |
718,371
-1,412
| -0.2% | -$48.2K |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.